CNR1 and Hepatic steatosis: Moreover, it has also been shown that, in mice exposed to alcohol, the deletion of CB1R, as well as the pharmacologic blockage of CB1R with a nonselective CB1R antagonist, such as SR141716 (the rimonabant drug), or a peripheral selective CB1R antagonist, was found to significantly reduce alcohol-induced liver steatosis [73,74].